SCHEMBL716888

SCHEMBL716888

COC(=O)Nc1ccc(C)c(NC(=O)OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
MAPK1 P28482 2/20 0.57
LMNA P02545 2/20 0.57
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.53
EGFR P00533 2/20 0.52
KDR P35968 2/20 0.52
MAPT P10636 6/20 0.50
FAAH O00519 1/20 0.50
CYP3A4 P08684 1/20 0.50
NLRP3 Q96P20 1/20 0.50
AGPAT2 O15120 1/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
PKM P14618 1/20 0.49
ATM Q13315 1/20 0.48
HTT P42858 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29922263 1.00 ALDH1A1 (0.57) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL31267143 0.93 HPGD (0.51) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL13104572 0.93 MAPT (0.56) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL18209634 0.93 HPGD (0.51) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL13104517 0.93 MAPT (0.56) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL13202313 0.91 SMN1; SMN2 (0.62) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL13104568 0.91 MAPT (0.58) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL13104616 0.91 SMN1; SMN2 (0.62) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL13104533 0.91 MAPT (0.58) ALDH1A1MAPK1LMNASMN1; SMN2MAPT
SCHEMBL26887084 0.91 NLRP3 (0.61) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4069240-A GROUP 8 METAL CATALYST UNIROYAL, INC. (US) 1978-01-17 US claimed
US-3962302-A Production of isocyanates from esters of carbamic acids (urethanes) ATLANTIC RICHFIELD COMPANY (US) 1976-06-08 US claimed
WO-2023008572-A1 ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR 広栄化学株式会社 2023-02-02 WO disclosed
US-11565997-B2 Method for preparing dicarbamate compounds from diamines and the catalyst thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2023-01-31 US disclosed
US-20220259380-A1 PROCESS FOR THE DECOMPOSITION OF POLYETHER-POLYURETHANE COVESTRO DEUTSCHLAND AG (DE) 2022-08-18 US disclosed
EP-3630717-B1 A PROCESS FOR THE SYNTHESIS OF AROMATIC CARBAMATES COUNCIL SCIENT IND RES (IN) 2022-02-09 EP disclosed
US-20220002236-A1 The method for preparing dicarbamate compounds from diamines and the catalyst thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2022-01-06 US disclosed
EP-3293173-B1 METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2021-07-28 EP disclosed
EP-3625210-B1 SILICA-BASED ZINC CATALYSTS. THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2021-06-23 EP disclosed
EP-3838892-A1 METHOD FOR PRODUCING ISOCYANATE Asahi Kasei Kabushiki Kaisha (JP) 2021-06-23 EP disclosed
EP-2980066-B1 METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2021-04-21 EP disclosed
EP-0014406-B1 PROCESS FOR THE SEPARATION OF SELENIUM, SELENIUM COMPOUNDS, SULFUR AND/OR SULFUR COMPOUNDS FROM URETHANES CONTAINING THESE ELEMENTS AND/OR COMPOUNDS BAYER AG (DE) 1981-08-26 EP disclosed
EP-0028724-A1 Process for preparing aryl isocyanates by thermal decomposition of aryl urethanes BASF Aktiengesellschaft (DE) 1981-05-20 EP disclosed
EP-0028338-A2 Process for preparing aromatic di- and/or polyisocyanates BASF Aktiengesellschaft (DE) 1981-05-13 EP disclosed
US-4259511-A Process for separating selenium, selenium compounds, sulfur and/or sulfur compounds from polyurethanes containing these elements and/or compounds BAYER AKTIENGESELLSCHAFT (DE) 1981-03-31 US disclosed
EP-0016948-A1 Process for preparing urethanes BAYER AG (DE) 1980-10-15 EP disclosed
EP-0014406-A1 Process for the separation of selenium, selenium compounds, sulfur and/or sulfur compounds from urethanes containing these elements and/or compounds BAYER AG (DE) 1980-08-20 EP disclosed
US-4081472-A CATALYTIC, FROM A CARBAMATE MITSUI TOATSU CHEMICALS INC. (JA) 1978-03-28 US disclosed
US-4069240-A GROUP 8 METAL CATALYST UNIROYAL, INC. (US) 1978-01-17 US disclosed
US-3962302-A Production of isocyanates from esters of carbamic acids (urethanes) ATLANTIC RICHFIELD COMPANY (US) 1976-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11565997-B2 Method for preparing dicarbamate compounds from diamines and the catalyst thereof AOC1, PPOX, SMOX ALDH1A1 329/4885MAPK1 4093/4885LMNA 3789/4885
US-20220002236-A1 The method for preparing dicarbamate compounds from diamines and the catalyst thereof AOC1, DDO, PPOX ALDH1A1 372/4885MAPK1 4240/4885LMNA 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.